STAMFORD, Conn., Nov. 08, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is investigating Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL) (“Zentalis” or the “Company”) on behalf of the Company’s investors.
The investigation seeks to determine whether Zentalis’ board of directors has violated its fiduciary duty by instituting measures that impermissibly interfere with the ability of Zentalis stockholders to elect directors of their choosing.
Zentalis stockholders are encouraged to contact Abbott Cooper PLLC by calling (475) 333-0674, emailing ac@abbottlawyer.com or visiting our website at www.abbottlawyer.com for additional information about this investigation as well as their legal rights and options.
Abbott Cooper PLLC is dedicated to shareholders’ rights and empowering shareholders through strategic counsel and legal advocacy. For additional information about Abbott Cooper PLLC, please visit www.abbottlawyer.com.
CONTACT:
Abbott Cooper PLLC
Abbott Cooper
(475) 333-0674
www.abbottlawyer.com
Attorney advertising. Prior results do not guarantee a similar outcome.
Hereby we publish the opinion of the Supervisory Board of Enefit Green AS on the…
Bitcoin is now more correlated with gold, which reached another all-time high, while the US…
If BTC can break through the resistance level of $86,000, it may target higher levels,…
NEW YORK, April 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights…
Global Times: Feng Jicai leads efforts to preserve China's cultural heritage through art, literature, and…
Hanover, MA , April 20, 2025 (GLOBE NEWSWIRE) -- Boston Hemp Inc., a leader in…
This website uses cookies.